483 CSL Behring Recombinant Facility AG Jun 2014

483 CSL Behring Recombinant Facility AG Jun 2014

Burnell Henry FDA, Prabhu Raju FDA$119.00 - Available Now

FDA investigators audited the CSL Behring Recombinant Facility AG - Bern, Switzerland facility and issued inspectional observations (via FDA 483) on 19 Jun 2014.

Product details

  • Category: Biologics
  • Inspection end: 19 Jun 2014
  • Location: Bern, Switzerland
  • FEI: 3002806716
Add To Cart